NGL Fine Chem Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524774 |
NSE Symbol : NGLFINE |
P/E(TTM) : 34.11 |
ISIN Demat : INE887E01022 |
Div & Yield% : 0.08 |
EPS(TTM) : 62.36 |
Book Value(₹) : 425.25 |
Market Cap(₹Cr) : 1,314.49 |
Face Value(₹) : 5.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 88.03 | 95.61 | 84.81 | 79.44 | 69.11 | 74.17 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 88.03 | 95.61 | 84.81 | 79.44 | 69.11 | 74.17 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 6.27 | 4.16 | 4.19 | 3.76 | 3.80 | 1.45 |
Total Income | 94.30 | 99.77 | 89.00 | 83.20 | 72.92 | 75.63 |
Total Expenditure | 81.72 | 83.01 | 73.86 | 66.31 | 61.51 | 62.31 |
PBIDT | 12.59 | 16.76 | 15.14 | 16.89 | 11.40 | 13.32 |
Interest | 0.44 | 0.46 | 0.28 | 0.36 | 0.24 | 0.32 |
PBDT | 12.14 | 16.30 | 14.86 | 16.53 | 11.16 | 13.00 |
Depreciation | 2.14 | 2.06 | 2.07 | 2.02 | 2.00 | 1.92 |
Tax | 1.83 | 3.28 | 3.51 | 3.44 | 1.18 | 2.95 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.35 | 0.11 | 0.38 | 0.11 | 0.17 | -0.40 |
Reported Profit After Tax | 7.83 | 10.85 | 8.90 | 10.97 | 7.81 | 8.53 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 7.83 | 10.85 | 8.90 | 10.97 | 7.81 | 8.53 |
EPS (Unit Curr.) | 12.67 | 17.56 | 14.40 | 17.76 | 12.63 | 13.81 |
EPS (Adj) (Unit Curr.) | 12.67 | 17.56 | 14.40 | 17.76 | 12.63 | 13.81 |
Calculated EPS (Unit Curr.) | 12.67 | 17.56 | 14.40 | 17.76 | 12.63 | 13.81 |
Calculated EPS (Adj) (Unit Curr.) | 12.67 | 17.56 | 14.40 | 17.76 | 12.63 | 13.81 |
Calculated EPS (Ann.) (Unit Curr.) | 50.67 | 70.24 | 57.60 | 71.02 | 50.54 | 55.23 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 50.67 | 70.24 | 57.60 | 71.02 | 50.54 | 55.23 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 14.30 | 17.53 | 17.85 | 21.26 | 16.50 | 17.96 |
PBDTM(%) | 13.79 | 17.05 | 17.52 | 20.81 | 16.15 | 17.53 |
PATM(%) | 8.89 | 11.35 | 10.49 | 13.81 | 11.30 | 11.50 |